Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTSD Prevention Using Oral Hydrocortisone
NCT04924166Phase 2Completed
- Start
- Jan 2022
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of hydrocortisone in post-traumatic stress disorder (PTSD). Started Jan 2022; status: completed.
02
Drugs
hydrocortisone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04924166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04924166.